Research

  • Military mild TBI outcomes vary considerably, study finds

    Long-term outcomes for combat veterans and service members with mild TBI (traumatic brain injury) vary widely, a 10-year study has found. While most people with mild TBI had a sustained recovery, some saw symptoms worsen over time. The findings could help identify those at high risk of later psychological, neurobehavioural or cognitive problems before they [...]

  • Research paves way for precision therapy for childhood TBI

    Researchers found a paediatric TBI biomarker that could guide precision rehabilitation after traumatic brain injury (TBI). The study identified reversible DNA changes, called epigenetic modifications, that may act as dynamic markers of recovery. Complicated traumatic brain injury usually requires at least an overnight hospital stay, unlike concussion, which often resolves within weeks. The [...]

  • Researchers detect early brain changes linked to future psychosis

    Researchers mapped brain network differences in people at high risk of psychosis, offering clues to how the illness begins. The study used neuroimaging (detailed brain scans) to spot early, network-level changes in more than 3,000 people at varying levels of risk. Those at clinical high risk, meaning people with early warning signs of psychosis, had [...]

  • Round up: second FDA indication extension for rehabilitation device, and more

    Neuro Rehab Times explores the latest business developments in the world of neurorehabilitation MedRhythms and Edwards Health Care Services enter into agreement MedRhythms, a neurologic and physical rehabilitation company with the world's first prescription music platform, has announced a strategic partnership with Edwards Health Care Services (EHCS), a provider of direct-to-home medical products. The partnership [...]

  • AI neurology market to reach US$2.5bn by 2030

    The AI neurology market will grow from US$705.6m in 2025 to US$2.5bn by 2030, driven by rising neurological disorders. The projected growth represents a compound annual growth rate of 28.9 per cent over the five-year period, as healthcare systems increasingly adopt AI tools for diagnosis and treatment of brain conditions. AI technologies are transforming how [...]

  • Bayer stroke drug sees positive results in clinical trials

    Asundexian reduced recurrent stroke without extra major bleeding in a phase III trial of over 12,300 patients on standard antiplatelets, according to topline results from Bayer. The once-daily oral medicine lowered the risk of repeat strokes in people who had a non-cardioembolic ischaemic stroke or a high-risk transient ischaemic attack (TIA). Non-cardioembolic strokes are not [...]

  • Neurorehab round up

    NR Times explores the latest research developments in the world of neurorehabilitation ​​Brain stimulation improves vision recovery after stroke Hemianopia is a condition that causes loss of half of the visual field (the “vertical midline”), which can happen following stroke and can severely affect daily activities such as reading, driving, or just walking through a [...]

  • Potential treatment could prevent brain damage in premature babies

    A Swedish study reports a potential treatment to prevent premature baby brain damage, using a new prenatal brain model. Researchers observed how cerebral haemorrhages (bleeding in the brain) affect stem cells during preterm birth and successfully tested an antidote that reduced the damage. They identified how neural stem cells in preterm infants are harmed when [...]

  • Drug could significantly slow MND progression, scientists say

    Scientists have discovered a new medicine that they say offers hope of substantially slowing the progress of motor neurone disease (MND). The drug, named M102, works by protecting nerve cells damaged by MND. Preclinical studies of the drug conducted with mice show improvement in movement and nerve function. Researchers are now hopeful the [...]

  • Simple test predicts Parkinson’s risk nine years before diagnosis

    A simple walking test that times how quickly people turn could flag Parkinson's nearly nine years before diagnosis. The finding could help spot patients in the prodromal phase – the earliest stage when brain damage starts but symptoms are subtle. This window can last years before tremor and movement problems prompt diagnosis. The [...]